+

WO1999036533A3 - Acide nucleique correspondant a une mutation associee a des cholestases - Google Patents

Acide nucleique correspondant a une mutation associee a des cholestases Download PDF

Info

Publication number
WO1999036533A3
WO1999036533A3 PCT/NL1999/000033 NL9900033W WO9936533A3 WO 1999036533 A3 WO1999036533 A3 WO 1999036533A3 NL 9900033 W NL9900033 W NL 9900033W WO 9936533 A3 WO9936533 A3 WO 9936533A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
cholestasis
bile
intrahepatic cholestasis
syndromes
Prior art date
Application number
PCT/NL1999/000033
Other languages
English (en)
Other versions
WO1999036533A2 (fr
Inventor
Laura N Bull
Nelson B Freimer
Roderick H J Houwen
Alexander S Knisely
Ludmila Pawlikowska
Eijk Michiel J T Van
Original Assignee
Academisch Ziekenhuis Utrecht
Laura N Bull
Nelson B Freimer
Roderick H J Houwen
Alexander S Knisely
Ludmila Pawlikowska
Eijk Michiel J T Van
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academisch Ziekenhuis Utrecht, Laura N Bull, Nelson B Freimer, Roderick H J Houwen, Alexander S Knisely, Ludmila Pawlikowska, Eijk Michiel J T Van filed Critical Academisch Ziekenhuis Utrecht
Priority to AU19863/99A priority Critical patent/AU1986399A/en
Priority to EP99900717A priority patent/EP1047786A2/fr
Publication of WO1999036533A2 publication Critical patent/WO1999036533A2/fr
Publication of WO1999036533A3 publication Critical patent/WO1999036533A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

L'invention se rapporte à la maladie gastro-intestinale chez l'humain, et plus spécifiquement à la maladie du foie, à la formation biliaire et à la sécrétion d'acide biliaire. L'invention se rapporte en particulier à des affections gastro-intestinales caractérisées par la cholestase, telle que, par exemple, la cholestase intrahépatique bénigne récidivante et la cholestase intrahépatique familiale évolutive ou autres troubles liés à un écoulement biliaire ou une sécrétion d'acide biliaire déficients, notamment chez les mammifères. L'invention porte sur un acide nucléique isolé et/ou recombinant ou un fragment fonctionnel ou un homologue dudit acide, provenant d'un gène, lequel gène opère une mutation chez des patients présentant une cholestase intrahépatique bénigne récidivante (BRIC) ou une cholestase intrahépatique familiale évolutive (PFIC). Ledit acide nucléique présente, chez l'humain, une séquence sensiblement identique à la séquence d'acide nucléique indiquée dans le dessin no 5.
PCT/NL1999/000033 1998-01-16 1999-01-18 Acide nucleique correspondant a une mutation associee a des cholestases WO1999036533A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU19863/99A AU1986399A (en) 1998-01-16 1999-01-18 Nucleic acid corresponding to mutation associated with cholestasis syndromes
EP99900717A EP1047786A2 (fr) 1998-01-16 1999-01-18 Acide nucleique correspondant a une mutation associee a des cholestases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7175298P 1998-01-16 1998-01-16
US60/071,752 1998-01-16

Publications (2)

Publication Number Publication Date
WO1999036533A2 WO1999036533A2 (fr) 1999-07-22
WO1999036533A3 true WO1999036533A3 (fr) 1999-09-23

Family

ID=22103353

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL1999/000033 WO1999036533A2 (fr) 1998-01-16 1999-01-18 Acide nucleique correspondant a une mutation associee a des cholestases

Country Status (3)

Country Link
EP (1) EP1047786A2 (fr)
AU (1) AU1986399A (fr)
WO (1) WO1999036533A2 (fr)

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
ARNELL, H. ET AL.: "Progressive familial intrahepatic cholestasis (PFIC): evidence for genetic heterogeneity by exclusion of linkage to chromosome 18q21-q22", HUMAN GENETICS, vol. 100, no. 3-4, September 1997 (1997-09-01), pages 378 - 381, XP002109429 *
BULL, L.N. ET AL.: "A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis", NAT GENET, vol. 18, no. 3, March 1998 (1998-03-01), pages 219-24, XP002109432 *
BULL, L.N. ET AL.: "Fine-resolution mapping by haplotype evaluation: the examples of PFIC1 and BRIC", HUMAN GENETICS, vol. 104, no. 3, March 1999 (1999-03-01), pages 241 - 248, XP002109434 *
BULL, L.N. ET AL.: "Localization of the BRIC/PFIC1 gene to a 250 kb interval through haplotype analysis", AMERICAN JOURNAL OF HUMAN GENETICS, vol. 61, no. 4, October 1997 (1997-10-01), usa, pages a269, XP002109436 *
SINKE, R. J. ET AL.: "Benign recurrent intrahepatic cholestais (BRIC): evidence of genetic heterogeneity and delimitatiomn of the BRIC locus to a 7-cM interval between D18S69 and D18S64", HUMAN GENETICS, vol. 100, no. 3-4, September 1997 (1997-09-01), pages 382 - 387, XP002109430 *
STRAUTNIEKS, S.S. ET AL.: "Locus heterogeneity in progressive familial intrahepatic cholestasis", JOURNAL OF MEDICAL GENETICS, vol. 33, no. 10, October 1996 (1996-10-01), pages 833 - 836, XP002109431 *
TANG ET AL: "A subfamily of P-Type ATPases with aminophospholipid transporting activity", SCIENCE, vol. 272, 7 June 1996 (1996-06-07), pages 1495 - 1497, XP002085282, ISSN: 0036-8075 *
TYGSTRUP, N. ET AL.: "Recurrent familial intrahepatic cholestasis in the Faeroe Islands. Phenotypic heterogeneity but genetic homogeneity", HEPATOLOGY, vol. 29, no. 2, February 1999 (1999-02-01), pages 506 - 508, XP002109433 *

Also Published As

Publication number Publication date
AU1986399A (en) 1999-08-02
WO1999036533A2 (fr) 1999-07-22
EP1047786A2 (fr) 2000-11-02

Similar Documents

Publication Publication Date Title
EP2261348A3 (fr) Antigènes de Neisseria meningitidis et compositions
WO2002100347A3 (fr) Promedicaments d'analogues de gaba, compositions et utilisations desdits promedicaments
EP0893494A3 (fr) Aspartyl ARNt synthétase de Chlamydia trachomatis
WO2002000724A3 (fr) Molecules de recepteur de lymphopoietine de stroma thymique et utilisations de celles-ci
WO2001070977A3 (fr) Molecules analogues au recepteur du facteur de croissance du fibroblaste, et leurs utilisations
IL135688A0 (en) Human checkpoint kinase, hcds1, compositions and methods
AU5799200A (en) Lpl variant therapeutics
WO2002086156A3 (fr) Nouveaux polynucleotides et nouveaux polypeptides du gene ifn$g(a)-17
CA2115579A1 (fr) Allergene du pollen de seigle
WO2001046260A3 (fr) Nouveaux membres de la superfamille des immunoglobulines apex-1, apex-2 et apex-3 et leurs utilisations
WO2001042474A3 (fr) Molecules de type interferon et utilisations
WO2000014206A3 (fr) Cellulase mutante egiii, adn codant ces compositions d'egiii et leurs procedes de preparation
WO1999036533A3 (fr) Acide nucleique correspondant a une mutation associee a des cholestases
WO2002000723A3 (fr) Molecules de recepteur de lymphopoietine de stroma thymique et utilisations de celles-ci
WO2005086825A3 (fr) Procedes et compositions pour le traitement de maladies associees a l'expansion microsatellitaire aberrante
EP0892056A3 (fr) GidA1 polypeptides de chlamydia trachomitis
WO2002060949A3 (fr) Glycoformes de flint
WO2002060947A8 (fr) Glycoformes d'analogue de flint
EP0905244A3 (fr) FolC de streptococcus
EP0900843A3 (fr) Polypeptide du type ffh de Streptoccus
WO2001090117A3 (fr) Haplotypes du gene p2ry1
WO2004072256A3 (fr) Variantes de cytochrome c et methodes de diagnostic de thrombocytopenie
WO2004005331A3 (fr) Peptides secretes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: KR

WWE Wipo information: entry into national phase

Ref document number: 1999900717

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999900717

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1999900717

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载